Biohit Oyj Class B logo

Biohit Oyj Class B (BIOBV)

Market Closed
12 Jun, 15:25
XHEL XHEL
2. 53
+0.03
+1.2%
35.37M Market Cap
- P/E Ratio
2.89% Div Yield
867 Volume
- Eps
2.5
Previous Close
Add Transaction
Day Range
2.48 2.58
Year Range
2.2 3.78
Want to track BIOBV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BIOBV closed today higher at €2.53, an increase of 1.2% from yesterday's close, completing a monthly decrease of -0.3937% or -€0.01. Over the past 12 months, BIOBV stock lost -31.4363%.
BIOBV is not paying dividends to its shareholders.
The last earnings report, released on Jun 13, 2024, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0415%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on CBOE (EUR).

BIOBV Chart

People also search for

Modulight Oy
1.14
+0.885%
Wulff-Yhtiöt Oyj
3.89
+4.0107%

Biohit Oyj Class B (BIOBV) FAQ

What is the stock price today?

The current price is €2.53.

On which exchange is it traded?

Biohit Oyj Class B is listed on XHEL.

What is its stock symbol?

The ticker symbol is BIOBV.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.89%.

What is its market cap?

As of today, the market cap is 35.37M.

Has Biohit Oyj Class B ever had a stock split?

No, there has never been a stock split.

Biohit Oyj Class B Profile

Biotechnology Industry
Healthcare Sector
Prof. Osmo Antero Suovaniemi M.D., Ph.D. CEO
XHEL Exchange
FI0009005482 ISIN
Finland Country
47 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Biohit Oyj is a pioneering biotechnology company based in Helsinki, Finland, established in 1988. The company focuses on manufacturing and marketing a broad range of diagnostic products and systems worldwide. These offerings are tailored for use across various sectors including research institutions, healthcare, and industry. Biohit Oyj's innovative solutions are designed to address the critical needs in diagnostic analysis, particularly in understanding and managing gastrointestinal diseases, vitamin deficiencies, and conditions like celiac disease and lactose intolerance. Additionally, Biohit Oyj is at the forefront of developing acetaldehyde-binding products aimed at reducing acetaldehyde exposure, which is implicated in several health conditions.

Products and Services

  • GastroPanel Unified Test Panel: An advanced stomach health check that assesses the status of the stomach lining and its functionality to aid in identifying potential risks and conditions.
  • GastroPanel Four-in-One Stomach Test: This comprehensive test provides crucial insights into gastric health, paving the way for targeted diagnostic and therapeutic measures.
  • GastroSoft Software Application: A dedicated software solution designed to assist clinicians and general practitioners with the interpretation of gastric health tests results.
  • Biohit Active B12 Test: Specifically developed to measure the levels of biologically active vitamin B12, critical for nervous system health and metabolism.
  • BIOHIT Total 25OH Vitamin D Test: Enables the precise determination of an individual's vitamin D status, aiding in the diagnosis of vitamin D deficiency.
  • Biohit Calprotectin Test: A diagnostic tool for measuring human calprotectin levels, instrumental in the assessment of inflammatory bowel diseases.
  • GastroPanel Quick Test NT: A rapid, quantitative immunochromatographic test for detecting Helicobacter pylori (H. Pylori) and atrophic gastritis, conditions linked with stomach cancer and ulcers.
  • BIOHIT Celiac Quick Test: Offers a swift diagnosis of celiac disease, enabling immediate steps to manage the condition through dietary adjustments.
  • Biohit ColonView Quick Test: A reliable test for the detection of fecal occult blood, an early indicator of colorectal cancer.
  • Biohit Helicobacter Pylori UFT300 and Quick Test Methods: These tests provide fast and accurate detection of H. pylori infection, a major cause of gastritis and peptic ulcers.
  • Lactose Intolerance Quick Test: Supports the diagnosis of lactose intolerance directly from a duodenal biopsy specimen, offering a quick route to dietary recommendations.
  • Acetaldehyde-Binding Products:
    • Acetium Capsules: Designed for individuals with low-acid or anacidic stomachs, these capsules bind acetaldehyde, reducing its harmful effects.
    • Acetium Lozenge: Aids in smoking cessation by binding acetaldehyde in the saliva, produced as a byproduct of smoking.
  • Monoclonal Antibodies: Developed for research in cellular pathology, neurobiology, oncology, and the detection of human gastric biomarkers, contributing significantly to the understanding and treatment of various diseases.

Contact Information

Address: Laippatie 1
Phone: 358 9773 861